propyl gallate has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Propyl Gallate: Antioxidant for foods, fats, oils, ethers, emulsions, waxes, and transformer oils.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A combination of sodium chenodeoxycholate and propyl gallate was used to enhance bioavailability of MEDI7219 at the site of maximal gastrointestinal absorption, targeted by enteric-coated tablets." | 1.62 | Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease. ( Balic, K; Grimsby, J; Huang, Y; Konkar, A; Liang, L; Naylor, J; Patel, C; Pechenov, S; Revell, J; Rosenbaum, AI; Subramony, JA; Tseng, L; Tyagi, P; Will, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pechenov, S | 1 |
| Revell, J | 1 |
| Will, S | 1 |
| Naylor, J | 1 |
| Tyagi, P | 1 |
| Patel, C | 1 |
| Liang, L | 1 |
| Tseng, L | 1 |
| Huang, Y | 1 |
| Rosenbaum, AI | 1 |
| Balic, K | 1 |
| Konkar, A | 1 |
| Grimsby, J | 1 |
| Subramony, JA | 1 |
1 other study available for propyl gallate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease.
Topics: Administration, Oral; Animals; Caco-2 Cells; Chemistry, Pharmaceutical; Chenodeoxycholic Acid; CHO C | 2021 |